Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 2 · 28.6%High 1 · 14.3%

Pneumococcal conjugate vaccine vs control vaccine

CRM197‐PCV7in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
6
2 studies · 39530 participants
Moderate

Pneumococcal conjugate vaccine vs control vaccine

CRM197‐PCV7in high‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 944 participants
Low

Pneumococcal conjugate vaccine vs control vaccine

OMPC‐PCV7in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1666 participants
Low

Pneumococcal conjugate vaccine vs control vaccine

PHiD‐CV10in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
6
2 studies · 12454 participants
Low

Pneumococcal conjugate vaccine vs control vaccine

PHiD‐CV11in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
34
1 study · 4968 participants
Moderate

Pneumococcal conjugate vaccine vs control vaccine

Adverse effects · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

The review found no eligible studies for this question.

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pneumococcal conjugate vaccine vs control vaccine

CRM197‐PCV7in low‐risk infants OMPC‐PCV7in low‐risk infants PHiD‐PC10 and PHiD‐PC11 in low‐risk infants CRM197‐PCV7/9 and CRM197‐PCV7 plus TIVin older children · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)

1 finding from 1 review

Pneumococcal conjugate vaccines for preventing acute otitis media in children 2020 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 77389 participants
High